Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Child & Adolescent Psychotherapy: Midterm Exam, Maternal Mental Health, & Medication, Assignments of Nursing

A comprehensive overview of key concepts in child and adolescent psychotherapy, maternal mental health, and medication considerations. It explores developmental considerations in therapy, the importance of family involvement, and the role of systems in child development. The document also delves into piaget's stages of cognitive development, highlighting the importance of tailoring educational approaches to different developmental stages. Additionally, it examines ethical considerations in the treatment of children and adolescents, including privacy, informed consent, and mandatory reporting. The document concludes with a discussion of maternal mental health, including the prevalence of postpartum depression and ethical considerations in prescribing medication during the perinatal period.

Typology: Assignments

2024/2025

Available from 02/07/2025

TheAcademicAce
TheAcademicAce 🇺🇸

592 documents

1 / 97

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
NR606 Midterm Exam (Latest Update)
Questions and Answers (100% Verified
Elaborations)
Steps for Obtaining Informed Consent
-Assess pt ability to understand medical info, tx options, to make a voluntary decision.
-Present relevant info with accuracy and sensitivity:
• diagnosis
• nature & purpose of tx options
• benefits, risks, burdens of all tx options, including forgoing tx
-Document informed consent conversation in the medical record, including all consent forms.
Underlying assumptions for child and adolescent psychotherapy
Developmental considerations
Family involvement
Systems involvement
Resiliency
Underlying assumptions for child and adolescent psychotherapy: Developmental considerations
-developmental level will impact how they:
• reason
• approach relationships
• regulate emotion and behavior
• communicate
-Developmental considerations
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe
pff
pf12
pf13
pf14
pf15
pf16
pf17
pf18
pf19
pf1a
pf1b
pf1c
pf1d
pf1e
pf1f
pf20
pf21
pf22
pf23
pf24
pf25
pf26
pf27
pf28
pf29
pf2a
pf2b
pf2c
pf2d
pf2e
pf2f
pf30
pf31
pf32
pf33
pf34
pf35
pf36
pf37
pf38
pf39
pf3a
pf3b
pf3c
pf3d
pf3e
pf3f
pf40
pf41
pf42
pf43
pf44
pf45
pf46
pf47
pf48
pf49
pf4a
pf4b
pf4c
pf4d
pf4e
pf4f
pf50
pf51
pf52
pf53
pf54
pf55
pf56
pf57
pf58
pf59
pf5a
pf5b
pf5c
pf5d
pf5e
pf5f
pf60
pf61

Partial preview of the text

Download Child & Adolescent Psychotherapy: Midterm Exam, Maternal Mental Health, & Medication and more Assignments Nursing in PDF only on Docsity!

NR606 Midterm Exam (Latest Update)

Questions and Answers (100% Verified

Elaborations)

Steps for Obtaining Informed Consent

  • Assess pt ability to understand medical info, tx options, to make a voluntary decision.
  • Present relevant info with accuracy and sensitivity:
  • diagnosis
  • nature & purpose of tx options
  • benefits, risks, burdens of all tx options, including forgoing tx
  • Document informed consent conversation in the medical record, including all consent forms. Underlying assumptions for child and adolescent psychotherapy Developmental considerations Family involvement Systems involvement Resiliency Underlying assumptions for child and adolescent psychotherapy: Developmental considerations
  • developmental level will impact how they:
  • reason
  • approach relationships
  • regulate emotion and behavior
  • communicate
  • Developmental considerations
  • inform the diagnostic process
  • guide tx planning Underlying assumptions for child and adolescent psychotherapy: Family involvement
  • Family involvement in tx & decision-making
  • a norm in child and adolescent psychotherapy
  • invite parents to share the hx of the child or adolescent's chief complaint & prior tx, medical & developmental hx, & behavioral info privately with the therapist ahead of the session
  • avoid feelings of criticism or discouragement
  • collaborate with parent or caregiver as a tx partner Underlying assumptions for child and adolescent psychotherapy: Systems involvement
  • Therapists must consider the systems that surround children & adolescents & promote their development
  • family
  • school
  • peers
  • the community
  • Therapy can help promote the child/adolescent's socioemotional competence
  • help develop a community support system Underlying assumptions for child and adolescent psychotherapy: Resiliency
  • therapist work to promote resiliency in children & adolescents
  • using strength-based orientation
  • supports:
  • functioning
  • Referral
  • Guidance to tx provides those identified as needing more extensive tx with access to specialty care Medication-Assisted Treatment (MAT) Treatment for opioid use disorder combining the use of medications (methadone, buprenorphine, or naltrexone) with counseling and behavioral therapies. Mental health and youth
  • 13% of children ages 8-15 experience a mental health condition
  • 50% of children ages 8-15 experiencing a mental health condition do not receive tx
  • 13 - 20% of children living in the U.S. (1 out of 5 children) experience a mental health condition in a given year
  • 17% of high school students seriously consider suicide
  • 1/2 of all lifetime cases of mental illness begin by age 14 Barriers to Mental Health Treatment in Children and Adolescents
  • lack of sufficient information or access to services
  • stigmas or negative perceptions towards mental health services
  • many drop out before receiving effective treatment, often due to:
  • poverty
  • language barriers
  • living in communities with scarce resources
  • stressors such as ➣problems in the family ➣violence in the community

➣unstable housing ➣unemployment ➣food insecurity

  • Cost
  • scheduling conflicts
  • long waitlists for services
  • high staff turnover Prescribing Considerations for Children and Adolescents
  • physiologic factors impact pediatric med selection & dosing
  • Children, more rapid metabolism than adults, may require larger dose of med per unit of body weight
  • Around puberty, pharmacokinetic properties reach adult parameters
  • dosing after puberty may need to be decreased
  • Developmental considerations
  • attuned to signs of adverse effects, younger children may not be able to communicate complaints Kassia, a 5-year-old, is prescribed a stimulant medication for ADHD (Attention Deficit Hyperactivity Disorders) for the first time. Consider Piaget's stages, match the developmentally-appropriate education statements with the correct client: "It's kind of like you've got a great bike. The brakes just need some fixing. The medication is like fixing the brakes." "This medication can help you ignore distractions so you can complete tasks. They can also help with self-control, which ma "Do you know how it's sometimes hard for you to sit still and pay attention at school? This medicine will help you."

"This medication can help you ignore distractions so you can complete tasks. They can also help with self-control, which may help you get along better with your friends and parents. Do you have any concerns about taking the medication?" Rationale: Tamika is in the Formal Operational stage. This stage typically occurs at age 12 and up. Adolescents and young adults begin to reason abstractly and can consider hypothetical problems. They begin to think more about moral, philosophical, ethical, social, and political issues. Addressing Parental Concerns: Collaborative Treatment Plans

  • tx plans for children typically made in collaboration with parents or guardians
  • Collaboration between the PMHNP, clients, and families when creating the treatment plan is key to ensuring the plan meets the client's needs and is comfortable and manageable for the family Ethical Considerations in the Treatment of Children and Adolescents Privacy and HIPAA Informed Consent Mandatory Reporting Ethical Considerations in the Treatment of Children and Adolescents: Privacy and HIPAA
  • parents have right to req access to a minor's mental health record, including symptoms, diagnosis, tx plan
  • circumstances may limit that right ➣see HIPAA fact sheet Ethical Considerations in the Treatment of Children and Adolescents: Informed Consent
  • Parents may decide whether to allow tx child is unable to provide true informed consent
  • children may not be able to give legal consent, should be included in discussions about med & tx whenever possible
  • encourage tx adherence Ethical Considerations in the Treatment of Children and Adolescents: Mandatory Reporting
  • PMHNPs mandated reporters in most states
  • required to report suspicions about abuse or neglect to the appropriate authorities
  • federal & state statutes include stipulations related to mandatory reporting
  • PMHNPs responsible for following all relevant statutes in their state of practice most common complication during the perinatal period? Mental health problems maternal mental health
  • Up to 1 in 5 women will suffer from a maternal mental health disorder like postpartum depression
  • <15% of women receive tx
  • 1 in 7 will experience depression during pregnancy
  • Up to 50% of women living in poverty will suffer from a maternal mental health disorder
  • Maternal mental health disorders impact the whole family, not just moms
  • More than 600,000 women will suffer from a maternal mental health disorder in the U.S. ever year
  • Anxiety & depression have risen 37% in teen girls. This will increase the number of women suffering postpartum depression in the future
  • Rates of depression are more than doubled in Black moms due to cumulative effects of stress called weathering Ethical Considerations in Maternal Mental Health Tx
  • Increased renal blood flow & GFR may speed the excretion Prescribing Considerations in Maternal Mental Health Tx: Lack of Evidence
  • psychoactive medications in the perinatal period
  • paucity of evidence regarding the true risks for the pregnant client and developing fetus ➣limited as pregnant women and newborns are frequently excluded from medication research Prescribing Considerations in Maternal Mental Health Tx: Switching Medications During Pregnancy
  • switching meds during pregnancy can create a high risk for destabilization of mental illness
  • puts both the client and fetus at risk for stress & trauma
  • increases the absolute # of substances to which the fetus is exposed ➣may increase risk for adverse outcomes
  • If stable on current med regimen, typically better to continue current regimen Allie is a 26-year-old who has been receiving treatment for bipolar I disorder for 3 years. Her symptoms have been in remission with lithium 500 mg twice daily. She also completed 12 weeks of interpersonal and social rhythm therapy (IPSRT) upon diagnosis and used the life charting methodology to track her symptoms. She calls her PMHNP and states "I just found out I'm pregnant. My partner and I were not expecting this, but we are excited! I am worried about what lithium will do to my baby. Sh schedule an appointment for Allie and her husband to discuss a treatment plan as soon as possible ask Allie to continue taking lithium at the current dose for now recommend that Allie begin tracking her mood, sleep schedule, and other symptoms Rationale: Rationale: The PMHNP should schedule an appointment as soon as possible to discuss Allie's treatment plan during her pregnancy. Discontinuation of medications for pregnancy is associated with a relapse rate of 80-100% for clients who take mood stabilizers; therefore, the client should not abruptly

cease taking lithium (Ortega et al., 2023). Clients with a diagnosis of bipolar disorder may benefit from tracking the symptoms of their illness, especially during stressful times. Although reassurance is appropriate, the PMHNP should not minimize the potential risks of continuing medication by telling the client that no harm will come to the baby. Discontinuation of medications for pregnancy is associated with a relapse rate of ___________% for clients who take mood stabilizers 80 - 100% Informed consent: pregnancy

  • must initiate discussion with pt regarding informed consent for tx
  • whether new symptoms during pregnancy or already established with care
  • risks of continuing current meds and the risks of stopping them
  • help pt process their risk factors & tx hx to make an informed decision
  • if must remain on high-risk medications such as valproic acid should be thoroughly evaluated by the multidisciplinary team including a perinatal psychiatrist
  • Documentation should note whether the woman plans to continue with treatment or discontinue the medication Kenya is a 36-year-old who has been taking fluoxetine for three years for major depressive disorder. Her symptoms are currently in remission, and she just found out that she is 7 weeks pregnant. She calls the PMHNP to discuss whether she should continue her medication during pregnancy. After the discussion, Kenya indicates that she will remain on her medication. Which of the following should be included in the discussion and documentation of the call with Kenya? Select all that apply. rare adve rare adverse effect of persistent pulmonary hypertension in the neonate
  • increases with higher doses
  • risks and benefits carefully considered, Consider the gestational age of the embryo and fetus
  • AVOID DURING PREGNANCY
  • valproic acid and carbamazepine are considered teratogenic Pregnancy Safety Considerations for Common Mental Health Treatment: Meds for Psychosis
  • atypical antipsychotic medications, particularly olanzapine and quetiapine
  • increased risk of gestational diabetes ➣D/Cing may not decrease the risk
  • increased risk of large for gestational age infants
  • Olanzapine increase the risk of musculoskeletal malformations in infants
  • Risperidone & quetiapine are the most used antipsychotics during pregnancy
  • Neither cause malformations
  • Antipsychotic meds may cause neonatal withdrawal symptoms
  • close monitoring of newborn several days after delivery Johnita has been taking sertraline 100 mg daily for 4 years for major depressive disorder. Her symptoms have fluctuated over the past year. She is 10 weeks pregnant. Which of the following is the most appropriate recommendation for Johnita? continue sertraline 100 mg daily decrease sertraline to 50 mg daily increase sertraline to 150 mg daily discontinue sertraline

continue sertraline 100 mg daily Rationale: Sertraline is considered a safe medication during pregnancy. The client's symptoms have fluctuated on her current medication dose; therefore, decreasing the dose may cause a relapse of symptoms. Alexandra has been taking lithium 1200 mg orally in two divided doses of 600 mg each for bipolar I disorder. She has been in remission of symptoms for 14 months. She is 7 weeks pregnant. Which of the following is the most appropriate recommendation for Alexandra? obtain serum lithium levels before tapering the lithium dose decrease dose to 600 mg daily decrease dose to 900 mg daily discontinue lithium and switch to lamotrigine obtain serum lithium levels before tapering the lithium dose Rationale: Lithium exposure during the first trimester has a small but statistically significant risk of cardiac malformations; the risk increases with higher dosages of the medication. Obtaining serum lithium levels before tapering the dose is indicated since Alexandra has bipolar I disorder and is stable. The development of the heart begins as early as the third week of gestation with the 4-chamber fetal heart formed by gestational week 7. By the time Alexandra is weaned the risk has passed as the heart is already formed. Although lamotrigine is considered safe during pregnancy, it may not be appropriate for clients who have experienced mania in the past. Saoirse takes aripiprazole 30 mg daily for a diagnosis of schizophrenia. She has taken the medication throughout her pregnancy and is now 34 weeks pregnant. She is concerned about the risks of neonatal withdrawal syndrome once her child is delivered. Which of the following is the most appropriate recommendation for Saoirse?

Safe for Bottle Feeding

  • Lithium
  • Lamotrigine
  • Clozapine Substance Use Disorders During the Perinatal Period
  • Perinatal SUDs are an urgent public health crisis
  • increasing across all groups of childbearing people ➣rates rising rural or low-income communities & those with Medicaid coverage for maternity care
  • greatest risk for life-threatening outcomes of SUDs is among people of color.
  • hallmark symptoms of SUDs: behavioral, physical, and psychological dependence
  • most used substance in the perinatal period is tobacco, followed by alcohol, cannabis, and other illicit drugs
  • use of prescription & illicit opioids also increasing
  • In US: 70, 000 maternal overdose deaths in 2018, 69% were related to opioid use Health Risks Associated with SUDs: Tobacco No tobacco product is considered safe for use during the perinatal period
  • Smoking-related pregnancy complications:
  • ectopic pregnancy
  • placental abruption
  • placenta previa
  • fetal mortality
  • stillbirth
  • preterm birth
  • low birth weight infants
  • Smoking-related effects on neonates:
  • sudden infant death syndrome
  • birth malformations ➣oral clefts ➣neural tube defects
  • Smoking-related effects on infants, children, and adolescents:
  • asthma
  • cognitive impairment
  • lower respiratory illness
  • ADHD
  • central nervous system tumors Health Risks Associated with SUDs: Alcohol
  • Drinking while pregnant costs the US $5.5 billion
  • CDC: no safe time to drink during pregnancy, no safe quantity of alcohol to consume while pregnant or trying to get pregnant
  • 1st trimester exposure correlates with the most significant alcohol-related birth outcomes
  • increased risk for miscarriage, stillbirth, congenital anomalies, low birth weight, small for gestational age, and preterm delivery
  • Lifelong effects of AUD on children:
  • fetal alcohol spectrum disorders (FASDs)
  • neurodevelopmental & CNS deficits
  • speech & language challenges
  • cognitive & behavioral deficits
  • impaired executive functioning
  • preterm labor
  • low birth weight
  • small for gestational age deliveries
  • adverse effects on fetal and adolescent brain growth
  • adverse effects on executive functioning skills
  • behavioral problems
  • adverse effects on academic achievement
  • All forms of cannabis have adverse effects, even medical marijuana Marijuana Possible Effects on Your Fetus
  • Disruption of brain development before birth
  • Smaller size at birth; higher risk of still birth
  • Higher chance of being born too early, especially when a woman uses both marijuana and cigarettes during pregnancy
  • Harm from second-hand marijuana smoke: Behavioral problems in childhood and trouble paying attention in school Marijuana Possible Effects on You
  • Permanent lung injury from smoking marijuana
  • Dizziness, putting you at risk for falls
  • Impaired judgment, putting you at risk of injury
  • Lower levels of oxygen in the body, which can lead to breathing problems Health Risks Associated with SUDs: Cocaine
  • majority of women addicted to cocaine are of childbearing age
  • linked with poor pregnancy-related outcomes:
  • premature rupture of membranes
  • placental abruption
  • preterm birth
  • low birth weight
  • small for gestational age deliveries, as well
  • long-term effects in children and adolescents:
  • lower short-term memory
  • child and adolescent delinquent behavior
  • earlier age of sexual activity
  • substance use Health Risks Associated with SUDs: Opioids
  • epidemic in the U. S.
  • Opioid use disorder (OUD) during pregnancy, including heroin & prescription opioids, increases risk of maternal life-threatening health problems & death by 50%
  • greater risk of eclampsia, heart attack or heart failure, & sepsis
  • Infants experience significant adverse effects:
  • neonatal abstinence syndrome (NAS)
  • increased risk of toxemia
  • low birth weight
  • respiratory complications
  • third trimester bleeding and mortality
  • postnatal growth deficiency
  • microcephaly
  • neurobehavioral problems
  • sudden infant death syndrome (SIDS)
  • 4x as many infants were born with neonatal abstinence syndrome (NAS) in 2014 than in 1999